Rxivist logo

TCF-1 in CD4 T cells regulates GVHD severity and persistence

By Rebecca Harris, Mahinbanu Mammadli, Adriana May, Qi Yang, Ivan Ting Hin Fung, Jyoti Misra Sen, Mobin Karimi

Posted 23 Mar 2021
bioRxiv DOI: 10.1101/2021.03.22.436492

Graft-versus-host disease (GVHD) is a leading cause of mortality following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Mature donor T cells in the graft mediate graft-versus-leukemia (GVL) responses against residual tumor cells, which may persist after pre-transplant conditioning regimens. Importantly, the same mature T cells also mediate GVHD. The transcription factor T Cell Factor-1 (TCF-1) is critical for T cell development in the thymus. Using a unique mouse model of allo-HSCT leading to GVHD, we investigated the role of TCF-1 in alloactivated T cell functioning and in GVHD. Here, we report that loss of TCF-1 in mature CD4 T cells reduces GVHD severity and persistence, improving survival of recipient mice. This was due to reduced proliferation, survival, and cytokine production of T cells, as well as increased exhaustion. Gene pathways involved in cytokine response, immune signaling, chemokine signaling, cell cycle, and T cell differentiation were altered by loss of TCF-1 in donor cells. Our companion paper shows that regulation of alloactivated CD4 T cells by TCF-1 differs from regulation of CD8 T cells, suggesting that TCF-1 plays a unique role in each subset. Therefore, targeting of TCF-1 or downstream signaling pathways may be an effective strategy for reducing GVHD following allo-HSCT.

Download data

  • Downloaded 128 times
  • Download rankings, all-time:
    • Site-wide: 147,971
    • In immunology: 4,478
  • Year to date:
    • Site-wide: 68,559
  • Since beginning of last month:
    • Site-wide: 46,777

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide